Egalet Corp
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2019 | $42 M | No. 1 | $10 to $50 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Egalet Corp chose not to state its revenue in its newest notice of a funding round (Feb 2019).
SEC Form D · Feb 2019
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Feb 2019
That is all the official record says: Egalet Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Atlas Venture Fund VII L.P. | Venture capital | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Index Venture Associates III Ltd | Fund or asset manager | not stated | not stated | Held Series A-2, B and B-1 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Index Ventures III (Delaware) L.P. | Venture capital | not stated | not stated | Held Series A-2, B and B-1 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Index Ventures III (Jersey) L.P. | Venture capital | not stated | not stated | Held Series A-2, B and B-1 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. | Venture capital | not stated | not stated | Held Series A-2, B and B-1 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Index Ventures Life VI (jersey) L.P. | Venture capital | not stated | not stated | Held Series A-2, B and B-1 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Omega Fund IV, L.P. | Fund or asset manager | not stated | not stated | Held Series A-1, A-2 and B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Sunstone Life Science Ventures Fund II K/S | Venture capital | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 1 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Barbara A. Carlin | SENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER | Feb 2019 |
| Mark M. Strobeck | EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER | Feb 2019 |
| Megan M. Timmins | SENIOR VICE PRESIDENT AND GENERAL COUNSEL | Feb 2019 |
| Patrick M. Shea | SENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER | Feb 2019 |
| Robert S. Radie | CHIEF EXECUTIVE OFFICER | Feb 2019 |
| Andrea S. Heslin Smiley | Director | Feb 2019 |
| Joseph P. Mcinnis | Director | Feb 2019 |
| Luke P. Duster | Director | Feb 2019 |
| Matthew P. Pauls | Director | Feb 2019 |
| Robert S. Radie | CHIEF EXECUTIVE OFFICER | Feb 2019 |
| Timothy P. Walbert | Director | Feb 2019 |
| Todd P. Holmes | Director | Feb 2019 |